14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $83.89 Wednesday, 24th Apr 2024 AXSM stock ended at $71.17. This is 2.61% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.61% from a day low at $69.92 to a day high of $73.14.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Aug 14, 2023 $69.28 $72.43 $67.52 $71.65 709 803
Aug 11, 2023 $70.50 $70.80 $69.12 $69.60 768 265
Aug 10, 2023 $70.00 $72.39 $69.87 $70.50 835 773
Aug 09, 2023 $72.74 $74.40 $69.43 $70.07 1 021 709
Aug 08, 2023 $72.61 $75.35 $72.02 $72.54 1 196 280
Aug 07, 2023 $75.98 $76.00 $69.51 $71.09 1 905 063
Aug 04, 2023 $75.25 $75.37 $73.28 $73.66 900 984
Aug 03, 2023 $72.35 $75.85 $71.89 $75.28 608 322
Aug 02, 2023 $76.68 $77.00 $73.08 $73.26 779 427
Aug 01, 2023 $78.40 $78.74 $76.86 $77.33 517 966
Jul 31, 2023 $79.00 $79.44 $77.57 $78.47 558 749
Jul 28, 2023 $78.33 $79.39 $76.52 $78.68 705 680
Jul 27, 2023 $76.63 $79.39 $76.40 $77.39 827 415
Jul 26, 2023 $73.00 $77.19 $72.83 $76.20 1 290 694
Jul 25, 2023 $73.50 $75.02 $73.00 $73.05 577 332
Jul 24, 2023 $75.35 $75.84 $72.85 $73.50 691 957
Jul 21, 2023 $74.99 $76.69 $74.44 $75.14 1 081 905
Jul 20, 2023 $74.02 $75.33 $73.50 $74.43 730 789
Jul 19, 2023 $74.50 $74.75 $72.92 $74.24 597 512
Jul 18, 2023 $73.59 $74.72 $72.98 $74.17 708 215
Jul 17, 2023 $73.88 $74.88 $72.81 $73.28 688 678
Jul 14, 2023 $73.16 $74.27 $72.60 $73.63 475 037
Jul 13, 2023 $74.60 $74.89 $72.46 $73.00 699 291
Jul 12, 2023 $74.70 $74.70 $72.91 $74.21 527 581
Jul 11, 2023 $73.34 $74.40 $73.14 $73.96 541 412
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT